维普期刊资源整合服务平台（V6.5）

277篇 您的检索式：作者名="BERRUTI"

选中清除导出查看参考文献查看引证文献引用追踪共14页首页上一页第1页下一页末页 /14 跳转

	题名	作者	年代	出处	被引量
1	Experimental analysis of volatile liquid injection into a fluidized bed显示文摘	A.H. Ahmadi Motlagh John R. Grace Cedric Briens Franco Berruti Masoumeh Farkhondehkavaki Majid Hamidi	2017	Particuology2017，15，5：	2
2	Thermal self-sustainability of biochar production by pyrolysis显示文摘	Berruti F Briens C	2011	Journal of Analytical and Applied Pyrolysis2011，91，1：	1
3	Effects of the somatostatin analog Lanreotide on the circulating level of chromogranin - A, prostate - specific antigen, and insulin like growth factor - 1 in advanced prostate cancer patients 显示文摘	Berruti A Dogliotti L Mosca A	2001	Prostate2001，47，3：	1
4	Solid circulation in a spoutfluid bed with draft tube 显示文摘	Berruti F Muir J R Behie L A	1988	The Canadian Journal of Chemical Engineering1988，66，12：	1
5	Circulating neuroendocrine markers in patients with prostate carcinoma显示文摘	Berruti A Dogliotti L Mosca A	2000	Cancer2000，88，11：	1
6	Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase Ⅱ study 显示文摘	Donadio M Ardine M Berruti A	2003	Cancer Chemother Pharmacol2003，52，2：	1
7	A pilot study evaluating serum pro-prostate-specific antigen in patients with rising PSA following radical prostatectomy显示文摘	SOTTILE A ORTEGA C BERRUTI A	2012	Oncol Lett2012，3，4：	1
8	Metabolic bone disease induced by prostate cancer: rationale for the use of bisphosphonates显示文摘	Dogliotti L Tucci M	2001	J Urol2001，166，6：	1
9	Solids circulation in spouted and spout-fluid beds with draft-tubes 显示文摘	Muir J R Berruti F Behie L A	1990	Chem Eng Commun1990，88，：	1
10	Multimodal management of stages III–IVa malignant thymoma显示文摘	S Bretti A Berruti C Loddo P Sperone C Casadio M Tessa F Ardissone G Gorzegno M Sacco E Manzin P Borasio G.L Sannazzari G Maggi L Dogliotti	2003	Lung Cancer2003，，1：	1
11	Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractary disease 显示文摘	Berruti A Mosca A Tucci M	2005	Endocr Relat Cancer2005，12，1：	1
12	Incidence of skeletalcomplications in patients with bone metastatic prostate cancerand hormone refractory disease: predictive role of boneresorption and formation markers evaluated at baseline 显示文摘	Berruti A Dogliotti L Bitossi R	2000	JUrol2000，164，4：	1
13	International ex- pert consensus on primary systemic therapy in the manage- ment of early breast cancer: highlights of the Fourth Sympo- sium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010) 显示文摘	Berruti A Generali D Kaufmann M	2011	J Natl Cancer Inst Monogr2011，，43：	1
14	Novel triboelectric meth- od flr characterizing the performance of nozzles injecting gas-at- omized liquid into a fluidized bed显示文摘	Ponoghese F Berruti F Briens C	2007	Chemical Etgineering and Processing2007，46，：	1
15	Chromogranin A expression in patients with hormone naive prostate cancer predicts the development of hormone refractory disease 显示文摘	Berruti A Mosca A Porpiglia F	2007	J Urol2007，178，3：	1
16	Low-dose monitored mitotane treatment achieves the therapeutic range with manageable side effects in patients with adrenocortical cancer显示文摘	Pia A Berruti A	2000	J Clin Endocrinol Metab2000，85，6：	1
17	Solid circulation ina spout-fluid bed with draft tube显示文摘	Berruti F Muir JR Behie LA	1988	CanadianJournal of Chemical Engineering1988，66，6：	1
18	Abiraterone and increased survival in metastatic prostate cancer 显示文摘	Berruti A Pia A Terzolo M	2011	N Engl J Med2011，365，8：	1
19	Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patients显示文摘	Tampellini M Berruti A Bitossi R	2006	Breast Cancer Res Treat2006，98，3：	1
20	Relationship between tu- mour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer显示文摘	Bottini A Berruti A Bersiga A	2001	Br J Cancer2001，85，8：	1

返回顶部每页显示：

共14页首页上一页第1页下一页末页 /14 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示